MGC Pharmaceuticals welcomes favourable chronic safety evaluation in CimetrA® pre-clinical trial

Europe-based pharmaceutical company MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) has received encouraging findings from the pre-clinical chronic...

Related Keywords

Ness Ziona ,Hamerkaz ,Israel ,Roby Zomer ,Lab Science In Action ,Drug Administration ,Pharmaceuticals Ltd ,Lab Science ,Investigational New Drug ,